Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by LeMaitre Vascular, Inc. on June 3, 2014. The filing details the voting results for corporate governance matters, including the election of directors and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on stockholder voting outcomes and does not contain financial performance data.
Material Changes
No material financial changes are reported in this filing. The document serves as a disclosure of corporate actions taken at the Annual Meeting rather than a report on operational or financial shifts.
Guidance, Outlook, and Management Commentary
The filing contains no guidance, outlook, or management commentary regarding future financial performance. It strictly documents the ratification of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2014, and the election of two Class II directors.
Important Facts for Investors to Verify
- Director Election Results: John A. Roush and Michael H. Thomas were elected as Class II directors for three-year terms expiring in 2017.
- Auditor Ratification: Stockholders ratified the appointment of Ernst & Young LLP for the 2014 fiscal year.
- Voting Participation: Of 15,602,458 shares entitled to vote, 13,887,135 shares were present in person or by proxy.
- Vote Breakdown:
- Proposal 1 (Directors): John A. Roush received 10,938,116 votes for; Michael H. Thomas received 10,936,606 votes for.
- Proposal 2 (Auditor): Received 13,080,854 votes for and 803,135 votes against.